Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2022-04-29
Summary
The purpose of this study is to determine whether Minoxidil treatment affects hair growth in patients with male pattern baldness or androgenetic alopecia.
Conditions
Interventions
- OTHER
-
Minoxidil
Over the counter Rogaine, twice a day for 8 weeks
- OTHER
-
Placebo
Sponsors & Collaborators
-
University of California, San Francisco
collaborator OTHER -
Kaiser Permanente
collaborator OTHER -
University Hospitals Cleveland Medical Center
lead OTHER
Principal Investigators
-
Pratima Karnik, Ph.D. · UH Case Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2012-04-30
- Completion
- 2012-04-30
Countries
- United States
Study Locations
More Related Trials
-
Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration
NCT04984707 ·Status: COMPLETED ·Phase: PHASE1
-
Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss
NCT06590779 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
NCT05888922 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
NCT00418730 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
NCT07273799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
NCT05910450 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)
NCT06556056 ·Status: COMPLETED ·Phase: NA
-
Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
NCT03852992 ·Status: WITHDRAWN ·Phase: PHASE2
-
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
NCT03535233 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
NCT01391156 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing
NCT02503137 ·Status: COMPLETED ·Phase: PHASE2
-
Minoxidil for Treating White Hair: A Randomized Controlled Trial
NCT06813963 ·Status: COMPLETED ·Phase: PHASE4
-
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
NCT05417308 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
NCT02154503 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
NCT02279823 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata
NCT05587257 ·Status: UNKNOWN ·Phase: NA
-
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
NCT02460289 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
NCT07011485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
NCT05914805 ·Status: COMPLETED ·Phase: PHASE3
-
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
NCT02486848 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
NCT05778825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
NCT02676310 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men
NCT05636904 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
NCT01325337 ·Status: COMPLETED ·Phase: PHASE2
-
Minoxidil Response Testing in Females With Female Pattern Hair Loss
NCT02206802 ·Status: COMPLETED